The main reason is that the increase in recycled fine powder will lead to an increase in CSH, CASH, NASH and other gelling products, whereas a decrease in phosphogypsum content will lead to a decrease in delayed AFt production. The gene discussed is CFLAR; the disease is metabolic dysfunction-associated steatohepatitis.